<DOC>
	<DOCNO>NCT01980355</DOCNO>
	<brief_summary>Major surgery result blood loss require blood transfusion and/or surgery . Tranexamic acid medication first introduce 1960s treatment heavy menstrual bleeding . Over past 20 year use study patient undergo open-heart surgery , liver transplantation , urologic surgery . We believe tranexamic acid may possibly decrease bleed related major surgery , result reduce blood loss , low blood transfusion rate , possibly decrease hospital cost related surgical hospital stay . In study , receive either drug tranexamic acid placebo . The placebo look like tranexamic acid , active ingredient . The treatment get choose chance , like flip coin . You equal chance give tranexamic acid placebo . In study , tranexamic acid placebo consider research .</brief_summary>
	<brief_title>TXA Study Major Oncologic Surgery</brief_title>
	<detailed_description>Neither study doctor choose treatment get . You equal chance give tranexamic acid placebo . Neither study doctor know treatment get . You receive one 1000 mg dose either tranexamic acid placebo immediately surgery . This dose tranexamic acid placebo give vein 15 minute . Information medical record relate surgery recovery time hospital collect medical staff assist study record study form . These study form label study number instead name . Additionally , return hospital within 30 day go home hospital , information hospital visit ( ) also collect medical record .</detailed_description>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Subjects undergo major oncologic surgery standard care purpose ( include : liver resection , radical cholecystectomy , pancreaticoduodenectomy [ Whipple procedure ] , esophagectomy , gastrectomy , colectomy , debulking hyperthermic intraperitoneal chemotherapy , prostatectomy , nephrectomy , partial nephrectomy ) Male female &gt; 18 year age Subject agree participate study provide informed consent Subjects history hypercoagulopathy , deep vein thrombosis pulmonary embolism Baseline creatinine level great 2.83 mg/dL Subjects know hypersensitivity tranexamic acid Adults unable provide inform consent Children Pregnant woman Prisoners NonEnglish speaking subject Any medical condition include mental illness substance abuse deem investigator likely interfere subject 's ability provide inform consent , cooperate take part research study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>cancer</keyword>
	<keyword>surgery</keyword>
	<keyword>oncology</keyword>
	<keyword>major</keyword>
	<keyword>surgical oncology</keyword>
	<keyword>tranexamic acid</keyword>
</DOC>